Medicare Enrolled
Dr. Neel Shah, MD
Urology Physician · Somerville, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shah?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shah
Dr. Neel Shah is an urology physician in Somerville, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Shah performed 5,844 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shah received a total of $5,291 from 48 pharmaceutical and/or device companies across 203 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 23% volume in NJ
$5,291 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,844
Medicare services
Top 23% in NJ for urology physician
Not available
Unique patients (not deduplicated)
$45
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,150 | $2 | $18 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
988 | $3 | $18 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
756 | $73 | $597 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
396 | $41 | $324 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
323 | $99 | $843 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
124 | $48 | $378 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
115 | $89 | $738 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
109 | $139 | $1,249 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 100 | $131 | $1,130 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
97 | $213 | $1,665 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
76 | $125 | $1,088 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
73 | $110 | $835 |
| Complicated change of bladder tube A complex surgical procedure to replace or modify a urinary diversion tube or conduit. This involves intricate manipulation of the urinary tract to ensure proper drainage and function. |
66 | $121 | $930 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
62 | $67 | $488 |
| Complicated insertion of bladder tube | 58 | $133 | $1,018 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
49 | $98 | $758 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
43 | $29 | $234 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
40 | $79 | $592 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
38 | $340 | $2,597 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
33 | $27 | $208 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
29 | $106 | $1,639 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
22 | $123 | $3,096 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
21 | $9 | $87 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
19 | $289 | $2,065 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
18 | $11 | $93 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
16 | $29 | $375 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
12 | $621 | $4,712 |
| Bladder stone removal, larger than 2.5 cm A procedure to crush, fragment, and remove bladder stones that are larger than 2.5 centimeters. |
11 | $396 | $2,915 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.4% high complexity
3.6% medium
95.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,291
Total received (2018-2024)
Avg $756/year across 7 years
Top 23% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
203
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,138
2023
$619
2022
$1,721
2021
$267
2020
$192
2019
$628
2018
$727
Payments by company (2024)
Boston Scientific Corporation
$153
Medtronic, Inc.
$150
Stryker Corporation
$131
COLOPLAST CORP
$118
Sumitomo Pharma America, Inc.
$67
UROGEN PHARMA, INC.
$67
180 Medical, Inc.
$66
PFIZER INC.
$62
Telix Pharmaceuticals
$36
Janssen Biotech, Inc.
$35
Endo Pharmaceuticals Inc.
$34
Ferring Pharmaceuticals Inc.
$33
ABBVIE INC.
$31
Dendreon Pharmaceuticals LLC
$26
Axonics, Inc.
$24
Astellas Pharma US Inc
$21
Antares Pharma, Inc.
$19
Olympus America Inc.
$19
Endo USA, Inc.
$17
Azurity Pharmaceuticals, Inc.
$15
IMMUNITYBIO, INC.
$14
Top 3 companies account for 38.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$925
Astellas Pharma US Inc
$592
Boston Scientific Corporation
$499
PROCEPT BioRobotics Corporation
$412
Penumbra, Inc.
$316
PFIZER INC.
$191
180 Medical, Inc.
$177
Sumitomo Pharma America, Inc.
$147
ABBVIE INC.
$138
Amgen Inc.
$137
Stryker Corporation
$131
Dendreon Pharmaceuticals LLC
$121
COLOPLAST CORP
$118
AbbVie Inc.
$105
Merck Sharp & Dohme LLC
$94
Myovant Sciences Inc.
$84
Olympus America Inc.
$82
Merck Sharp & Dohme Corporation
$82
Endo Pharmaceuticals Inc.
$76
UROGEN PHARMA, INC.
$67
Accord Healthcare, Inc.
$55
Axonics, Inc.
$50
Telix Pharmaceuticals
$49
Medtronic USA, Inc.
$49
Hollister Incorporated
$43
Janssen Pharmaceuticals, Inc
$42
Bayer HealthCare Pharmaceuticals Inc.
$35
Janssen Biotech, Inc.
$35
Gilead Sciences, Inc.
$33
Ferring Pharmaceuticals Inc.
$33
UroGen Pharma, Inc.
$32
Kowa Pharmaceuticals America, Inc.
$32
Esperion Therapeutics, Inc.
$30
Lilly USA, LLC
$29
Blue Earth Diagnostics Limited
$29
AbbVie, Inc.
$28
GlaxoSmithKline, LLC.
$27
Antares Pharma, Inc.
$19
ACCORD HEALTHCARE, INC.
$17
Endo USA, Inc.
$17
Azurity Pharmaceuticals, Inc.
$15
UROVANT SCIENCES INC
$15
IMMUNITYBIO, INC.
$14
Palette Life Sciences, Inc.
$14
MEDIVATION FIELD SOLUTIONS LLC
$14
Metuchen Pharmaceuticals
$13
AstraZeneca Pharmaceuticals LP
$12
Allergan, Inc.
$12
Top 3 companies account for 38.1% of all-time payments
Associated products mentioned in payments ›
1788 · ADSTILADRIN · ANKTIVA · ANORO · AVEED · AquaBeam Robotic System · Axonics · Axumin · BELSOMRA · BOTOX · CAMCEVI · Coloplast TFL Drive · Digital Flexible Ureteroscopes · ERLEADA · EVENITY · FARXIGA · GARDASIL 9 · GEMTESA · GENERAL UTERINE TISSUE REMOVAL · HD CAMERA HEAD · HORIZANT · ILLUCCIX · INTERSTIM · JANUVIA · JELMYTO · KEYTRUDA · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NEXLETOL · Nubeqa · ORGOVYX · Olympus Bronchoscopes · PROVENGE · Penumbra Ruby Coil · Prolia · REZUM · Rezum Generator · SEGLENTIS · SpaceOAR VUE System - 10mL · Stendra · TOVIAZ · TRULICITY · VaPro Plus Pocket · Veozah · XARELTO · XGEVA · XIAFLEX · XTANDI · XYOSTED · iTIND System · rezum Generator
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
132
County median income
$135,960
Nearest hospital to ZIP centroid (approximate)
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL - SOMERSET
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shah is a clinical cardiology specialist, with above-average Medicare volume (top 23% in NJ), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shah experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Shah performed 2,150 bcg treatment for bladder cancer services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shah receive payments from pharmaceutical companies?
Yes. Dr. Shah received a total of $5,291 from 48 companies across 203 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shah's costs compare to other urology physicians in Somerville?
Dr. Shah's average Medicare payment per service is $45. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Somerville
Browse urology physicians in Somerville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology